Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All zinc studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Zinc Deficiency and Post-acute Outcomes in Patients With COVID-19: A Six-Month Retrospective Cohort Analysis of 3,726 Patients

Hung et al., Cureus, doi:10.7759/cureus.71609
Oct 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 42% Improvement Relative Risk Hospitalization 24% Zinc for COVID-19  Hung et al.  Sufficiency Are zinc levels associated with COVID-19 outcomes? PSM retrospective 3,726 patients in multiple countries (Jan 2022 - Jul 2023) Lower mortality (p=0.045) and hospitalization (p<0.0001) c19early.org Hung et al., Cureus, October 2024 Favorszinc Favorscontrol 0 0.5 1 1.5 2+
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020, now with p = 0.00000032 from 46 studies, recognized in 17 countries.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 109 treatments. c19early.org
TriNetX PSM retrospective 3,726 post-acute COVID-19 patients showing significantly higher 6-month all-cause hospitalization and mortality with zinc deficiency. Zinc levels were measured in the three months before COVID-19 diagnosis.
risk of death, 42.4% lower, HR 0.58, p = 0.045, high zinc levels (≥70μg/dL) 1,863, low zinc levels (<70μg/dL) 1,863, inverted to make HR<1 favor high zinc levels (≥70μg/dL), propensity score matching, Cox proportional hazards.
risk of hospitalization, 23.9% lower, HR 0.76, p < 0.001, high zinc levels (≥70μg/dL) 1,863, low zinc levels (<70μg/dL) 1,863, inverted to make HR<1 favor high zinc levels (≥70μg/dL), propensity score matching, Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Hung et al., 16 Oct 2024, retrospective, multiple countries, peer-reviewed, 7 authors, study period 1 January, 2022 - 31 July, 2023. Contact: andy10271@gmail.com.
This PaperZincAll
Zinc Deficiency and Post-acute Outcomes in Patients With COVID-19: A Six-Month Retrospective Cohort Analysis of 3,726 Patients
Lun-Wu Hung, Mei-Yuan Liu, Tsung Yu, Kuo-Chuan Hung, Ya-Wen Tsai, Chih-Cheng Lai, Jheng-Yan Wu
Cureus, doi:10.7759/cureus.71609
Background Previous studies have suggested that zinc deficiency (ZD) may increase the risk of short-term mortality in patients with coronavirus disease 2019 . However, the relationship between zinc status and post-acute COVID-19 outcomes remains unclear. This study aimed to determine the association between ZD and long-term outcomes in patients with COVID-19. Methodology We conducted a retrospective cohort study using the TriNetX database, including patients aged 18 years or older diagnosed with COVID-19 between January 1, 2022, and July 31, 2023. Patients had documented serum or plasma zinc levels within three months before COVID-19 diagnosis and were not deceased or hospitalized in the first month of infection. They were categorized into ZD (zinc levels <70μg/dL) and control (zinc levels ≥70μg/dL) groups. After 1:1 propensity score matching for demographic and clinical variables, outcomes were assessed from 30 to 180 days post-diagnosis, including all-cause hospitalization, all-cause mortality, and four subphenotypes of post-acute COVID-19. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated. Results After matching, each group included 1,863 patients with balanced baseline characteristics. The ZD group had a higher incidence of all-cause hospitalization (25.3% vs. 20.3%; HR = 1.314; 95% CI = 1.148-1.505; p<0.001) and all-cause mortality (3.8% vs. 2.2%; HR = 1.735; 95% CI = 1.180-2.551; p=0.045) compared to the control group during the follow-up period. Among the four subphenotypes, only the cardiac and renal subphenotype showed a significantly higher risk in the ZD group (HR = 1.099; 95% CI = 1.002-1.205; p = 0.004). Conclusions ZD is associated with increased risks of long-term hospitalization, mortality, and increased risk in COVID-19 patients with cardiac and renal comorbidities. Monitoring and managing zinc levels may be important for improving long-term outcomes. Further research is warranted to explore the potential benefits of zinc supplementation in COVID-19 patients with ZD.
Additional Information Author Contributions All authors have reviewed the final version to be published and agreed to be accountable for all aspects of the work. Concept and design: Jheng-Yan Wu, Lun-Wu Hung Critical review of the manuscript for important intellectual content: Jheng-Yan Wu, Chih-Cheng Lai Acquisition, analysis, or interpretation of data: Lun-Wu Hung, Mei-Yuan Liu, Tsung Yu, Kuo-Chuan Hung, Ya-Wen Tsai, Chih-Cheng Lai Drafting of the manuscript: Lun-Wu Hung, Mei-Yuan Liu, Tsung Yu, Kuo-Chuan Hung, Ya-Wen Tsai Disclosures Human subjects: Consent was obtained or waived by all participants in this study. Institutional Review Board of the Chi Mei Medical Center issued approval 11302-E01. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
References
Berger, Shenkin, Schweinlin, ESPEN micronutrient guideline, et al. Cureus, doi:10.1016/j.clnu.2022.02.015
Hsu, Tsai, Wu, Liu, Lai, Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors, J Infect, doi:10.1016/j.jinf.2023.02.007
Jothimani, Kailasam, Danielraj, COVID-19: poor outcomes in patients with zinc deficiency, Int J Infect Dis, doi:10.1016/j.ijid.2020.09.014
Tabatabaeizadeh, Zinc supplementation and COVID-19 mortality: a meta-analysis, Eur J Med Res, doi:10.1186/s40001-022-00694-z
Trinetx, None
Tsai, Tsai, Wu, Huang, Liu et al., The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: a retrospective cohort study from the TriNetX network, J Infect, doi:10.1016/j.jinf.2023.01.006
Wu, Hsu, Tsai, The association between zinc deficiency, and clinical outcomes of COVID-19, J Infect, doi:10.1016/j.jinf.2023.06.021
Wu, Liu, Huang, Tsai, Lai, of 9 systematic review and meta-analysis of randomized controlled trials, Hung et al. Cureus, doi:10.1016/j.jinf.2023.01.023
Wu, Liu, Liu, Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19, J Med Virol, doi:10.1002/jmv.28866
Zhang, Zang, Xu, Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes, Nat Med, doi:10.1038/s41591-022-02116-3
{ 'indexed': { 'date-parts': [[2024, 10, 17]], 'date-time': '2024-10-17T04:22:05Z', 'timestamp': 1729138925694, 'version': '3.27.0'}, 'reference-count': 10, 'publisher': 'Springer Science and Business Media LLC', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2024, 10, 16]]}, 'DOI': '10.7759/cureus.71609', 'type': 'journal-article', 'created': { 'date-parts': [[2024, 10, 16]], 'date-time': '2024-10-16T12:15:54Z', 'timestamp': 1729080954000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Zinc Deficiency and Post-acute Outcomes in Patients With COVID-19: A Six-Month Retrospective ' 'Cohort Analysis of 3,726 Patients', 'prefix': '10.7759', 'author': [ {'given': 'Lun-Wu', 'family': 'Hung', 'sequence': 'first', 'affiliation': []}, {'given': 'Mei-Yuan', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tsung', 'family': 'Yu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kuo-Chuan', 'family': 'Hung', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ya-Wen', 'family': 'Tsai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chih-Cheng', 'family': 'Lai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jheng-Yan', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'reference': [ { 'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jinf.2023.06.021', 'article-title': 'The association between zinc deficiency, and clinical outcomes of ' 'COVID-19', 'volume': '87', 'author': 'Wu JY', 'year': '2023', 'unstructured': 'Wu JY, Hsu WH, Tsai YW, et al.. The association between zinc deficiency, ' 'and clinical outcomes of COVID-19. J Infect. 2023, 87:e63-7. ' '10.1016/j.jinf.2023.06.021', 'journal-title': 'J Infect'}, { 'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jinf.2023.01.023', 'article-title': 'The effect of zinc on the outcome of patients with COVID-19: a ' 'systematic review and meta-analysis of randomized controlled trials', 'volume': '86', 'author': 'Wu JY', 'year': '2023', 'unstructured': 'Wu JY, Liu TH, Huang PY, Tsai YW, Lai CC. The effect of zinc on the ' 'outcome of patients with COVID-19: a systematic review and meta-analysis ' 'of randomized controlled trials. J Infect. 2023, 86:e142-3. ' '10.1016/j.jinf.2023.01.023', 'journal-title': 'J Infect'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s40001-022-00694-z', 'article-title': 'Zinc supplementation and COVID-19 mortality: a meta-analysis', 'volume': '27', 'author': 'Tabatabaeizadeh SA', 'year': '2022', 'unstructured': 'Tabatabaeizadeh SA. Zinc supplementation and COVID-19 mortality: a ' 'meta-analysis. Eur J Med Res. 2022, 27:70. 10.1186/s40001-022-00694-z', 'journal-title': 'Eur J Med Res'}, { 'key': 'ref4', 'unstructured': 'TriNetX. (2024). Accessed. February 28, 2024: https://trinetx.com/.'}, { 'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jinf.2023.02.007', 'article-title': 'Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir ' 'for COVID-19 survivors', 'volume': '86', 'author': 'Hsu WH', 'year': '2023', 'unstructured': 'Hsu WH, Tsai YW, Wu JY, Liu TH, Lai CC. Post-acute hospitalization and ' 'mortality of nirmatrelvir plus ritonavir for COVID-19 survivors. J ' 'Infect. 2023, 86:e107-10. 10.1016/j.jinf.2023.02.007', 'journal-title': 'J Infect'}, { 'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jinf.2023.01.006', 'article-title': 'The risk of methicillin-resistant Staphylococcus aureus infection ' 'following COVID-19 and influenza: a retrospective cohort study from the ' 'TriNetX network', 'volume': '86', 'author': 'Tsai YW', 'year': '2023', 'unstructured': 'Tsai YW, Tsai CF, Wu JY, Huang PY, Liu TH, Lai CC. The risk of ' 'methicillin-resistant Staphylococcus aureus infection following COVID-19 ' 'and influenza: a retrospective cohort study from the TriNetX network. J ' 'Infect. 2023, 86:256-308. 10.1016/j.jinf.2023.01.006', 'journal-title': 'J Infect'}, { 'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.28866', 'article-title': 'Clinical efficacy of nirmatrelvir and ritonavir combination for ' 'treating diabetic patients with COVID-19', 'volume': '95', 'author': 'Wu JY', 'year': '2023', 'unstructured': 'Wu JY, Liu MY, Liu TH, et al.. Clinical efficacy of nirmatrelvir and ' 'ritonavir combination for treating diabetic patients with COVID-19. J ' 'Med Virol. 2023, 95:e28866. 10.1002/jmv.28866', 'journal-title': 'J Med Virol'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijid.2020.09.014', 'article-title': 'COVID-19: poor outcomes in patients with zinc deficiency', 'volume': '100', 'author': 'Jothimani D', 'year': '2020', 'unstructured': 'Jothimani D, Kailasam E, Danielraj S, et al.. COVID-19: poor outcomes in ' 'patients with zinc deficiency. Int J Infect Dis. 2020, 100:343-9. ' '10.1016/j.ijid.2020.09.014', 'journal-title': 'Int J Infect Dis'}, { 'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41591-022-02116-3', 'article-title': 'Data-driven identification of post-acute SARS-CoV-2 infection ' 'subphenotypes', 'volume': '29', 'author': 'Zhang H', 'year': '2023', 'unstructured': 'Zhang H, Zang C, Xu Z, et al.. Data-driven identification of post-acute ' 'SARS-CoV-2 infection subphenotypes. Nat Med. 2023, 29:226-35. ' '10.1038/s41591-022-02116-3', 'journal-title': 'Nat Med'}, { 'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.clnu.2022.02.015', 'article-title': 'ESPEN micronutrient guideline', 'volume': '41', 'author': 'Berger MM', 'year': '2022', 'unstructured': 'Berger MM, Shenkin A, Schweinlin A, et al.. ESPEN micronutrient ' 'guideline. Clin Nutr. 2022, 41:1357-424. 10.1016/j.clnu.2022.02.015', 'journal-title': 'Clin Nutr'}], 'container-title': 'Cureus', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.cureus.com/articles/310518-zinc-deficiency-and-post-acute-outcomes-in-patients-with-covid-19-a-six-month-retrospective-cohort-analysis-of-3726-patients', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 10, 16]], 'date-time': '2024-10-16T12:15:57Z', 'timestamp': 1729080957000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/310518-zinc-deficiency-and-post-acute-outcomes-in-patients-with-covid-19-a-six-month-retrospective-cohort-analysis-of-3726-patients'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 10, 16]]}, 'references-count': 10, 'URL': 'http://dx.doi.org/10.7759/cureus.71609', 'relation': {}, 'ISSN': ['2168-8184'], 'subject': [], 'published': {'date-parts': [[2024, 10, 16]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit